HK$1.62 9906.HK Honliv Healthcare HKSE after hours 26 Feb 2026: Oversold bounce
9906.HK stock: Honliv Healthcare at HK$1.62 after hours on 26 Feb 2026; oversold bounce outlook and Meyka AI forecast
9906.HK stock: Honliv Healthcare at HK$1.62 after hours on 26 Feb 2026; oversold bounce outlook and Meyka AI forecast
Intraday earnings spotlight on SHA0.DE stock ahead of 3 Mar 2026 report; Meyka AI analysis and EUR price outlook
AUGC.V stock reacts as Au Gold Corp files an NI 43-101 report for the Havelock Gold-Antimony acquisition, with TSXV conditional approval and closing near March 4. Key takeaways for Japan-based traders
After-hours volume spike in 5SY.SI stock on 26 Feb 2026; analysis, forecasts and Meyka AI grade for OneApex (SES)
KASH.CN stock falls 25% to CAD 0.015 on CNQ; analysis of liquidity, valuation and Meyka AI forecast
MMR.AX stock jumped 66.67% to A$0.005 on 26 Feb 2026; Meyka AI forecast points to A$0.010 monthly target
Salesforce stock faces Japan’s AI scare trade after the Anthropic shock. We assess Agentforce, a shift toward agent-based SaaS pricing, today’s CRM levels, and scenarios for JP investors.
USLQ stock rises to $0.009 on 26 Feb 2026; our analysis covers drivers, metrics, Meyka grade and a **$0.01** short-term forecast
Jefferies kept Hold on AWI; we analyze the $185 price target and investor impact for AWI analyst rating
Needham maintains Buy and lifts PT to $81 for LivaNova. LIVN analyst rating update and implications for investors